PA
INN

PharVision Advisers’s Summit Hotel Properties INN Stock Holding History

PharVision Advisers’s Portfolio INN Stock Details INN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-39,995
Closed -$220K – 839
2025
Q3 		$220K Buy
+39,995
New +$218K 0.12% 430

Other funds holding INN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LPC
Long Pond Capital New York $1.05B AUM 16.49% 1-Year Est. Return
H2CM
H/2 Credit Manager Stamford, Connecticut $500M AUM 24.68% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PharVision Advisers's INN Position: Q4 2025 in Review

PharVision Advisers sold out of Summit Hotel Properties (INN) in Q4 2025, closing a stake of 39,995 shares — an estimated $220K sold.

PharVision Advisers first reported a position in INN in Q3 2025 and held it in 1 quarter. The position peaked at $220K in Q3 2025. 203 funds tracked by Wall St. Rank hold INN as of Q4 2025.

  • PharVision Advisers reported no remaining Summit Hotel Properties position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 39,995 Summit Hotel Properties shares in Q4 2025, an estimated $220K.
  • PharVision Advisers first reported a position in Summit Hotel Properties in Q3 2025 and held it in 1 quarter.
  • PharVision Advisers's Summit Hotel Properties position peaked at $220K in Q3 2025.
  • 203 funds tracked by Wall St. Rank held Summit Hotel Properties as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.